Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilar Bummer: FDA Postpones Celltrion Infliximab Advisory Committee

Feb 26 2015

• By Derrick Gingery

Related Content

Saving Face? Cell Therapeutics Withdraws Pixantrone NDA Ahead Of Advisory Committee Review

Jan 30 2012

Related Companies

Celltrion, Inc.

Johnson & Johnson

Hospira, Inc.

Novartis AG

Amgen, Inc.

Apotex Inc.

Pfizer Inc.

Additional Topics

United States Advisory Committees BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window